| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer
1 company
Reich Kristian serves as a Chief Scientific Officer at MLTX. Across recent SEC filings that breaks down to 0 buys and 24 sells. Those positions are worth an estimated $45.1M at current prices.
Historically, Reich Kristian's trades have earned a strong insider score of 78/100 across 9 rated trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +25.8%.
The biggest single holding is MLTX (~$45.1M) as Chief Scientific Officer. The recent filings there lean toward selling, a net 666,261 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 27, 2026 | MLTX Moonlake Immunotherapeutics | Chief Scientific Officer | Sell | 1,100 | $20.00 | $22,000.00 | - | - | - | |
| Jul 22, 2026 | MLTX Moonlake Immunotherapeutics | Chief Scientific Officer | Sell | 52,448 | $20.02 | $1,049,960.00 | -1.0% | - | - | |
| Jul 20, 2026 | MLTX Moonlake Immunotherapeutics | Chief Scientific Officer | Sell | 43,700 | $20.09 | $877,933.00 | -1.6% | - | - | |
| Jul 15, 2026 | MLTX Moonlake Immunotherapeutics | Chief Scientific Officer | Sell | 16,105 | $20.01 | $322,261.05 | -0.6% | - | - | |
| Jun 17, 2026 | MLTX Moonlake Immunotherapeutics | Chief Scientific Officer | Sell | 150,000 | $19.01 | $2,851,000.00 | -1.7% | - | - | |
| Dec 9, 2025 | MLTX Moonlake Immunotherapeutics | Chief Scientific Officer | Sell | 202,908 | $14.85 | $3,012,462.44 | -73.6% | +25.9% | - | |
| Feb 28, 2024 | MLTX Moonlake Immunotherapeutics | Chief Scientific Officer | Sell | 118,922 | $55.00 | $6,540,710.00 | -1.9% | -26.6% | -26.5% | |
| Feb 21, 2024 | MLTX Moonlake Immunotherapeutics | Chief Scientific Officer | Sell | 21,078 | $57.33 | $1,208,418.49 | -0.3% | -27.1% | -21.4% | |
| Feb 16, 2024 | MLTX Moonlake Immunotherapeutics | Chief Scientific Officer | Sell | 60,000 | $60.91 | $3,654,800.00 | -0.6% | -31.8% | -27.9% |